OsteoSee

Company Overview

Snapshot

Founded in December 2017 by Ze'ev Weinfeld and Shimon Abboud (Arad), OsteoSee operates with 1–10 employees. The company secured a Seed funding round in December 2017 from eHealth Ventures. OsteoSee ceased to operate in January 2022.

Business overview

OsteoSee is a clinical-stage company developing a comprehensive solution for bone-health screening and monitoring, targeting primary care clinics and home use. The company utilizes proprietary parametric electrical impedance tomography (pEIT) technology to offer a tabletop system for rapid diagnosis and frequent in-office monitoring, as well as a wristband system connected to a smartphone for remote and self-monitoring of osteoporosis treatment. OsteoSee operates in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Medical Devices, addressing the unmet need for osteopenia and osteoporosis screening at the point of care.

Company Intelligence Q&A

What is OsteoSee's primary focus?

OsteoSee is focused on bringing bone-health screening and monitoring to primary care clinics and homes, developing a comprehensive solution for accurate bone health management.

When was OsteoSee founded and by whom?

OsteoSee was founded in December 2017 by Ze'ev Weinfeld and Shimon Abboud (Arad).

What technology does OsteoSee use for its solutions?

OsteoSee uses proprietary parametric electrical impedance tomography (pEIT) technology for its bone mineral density (BMD) measurement solutions.

What products does OsteoSee offer?

OsteoSee offers two main products: OsteoSee Clinic, a tabletop system for physicians, and OsteoSee Home, a wristband system connected to a smartphone for remote monitoring.

What is the current operational status of OsteoSee?

OsteoSee ceased to operate in January 2022.